Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Efficacy of Intralesional acyclovir in treatment of cutaneous warts: Group A : 0.1 ml of acyclovir (70mg/ml) will be injected intralesionally into the base of each wart every 2 weeks fo
Sponsors
Akepati Samhitha
Eligibility
Inclusion criteria
Inclusion criteria: Patients of both genders aged above 18 years and below 60 years with cutaneous warts. Patients willing to give written informed consent
Exclusion criteria
Exclusion criteria: Pregnant and lactating women women planning for pregnancy patients who received treatment for warts for atleast one month before study Patients on antiviral medications for other conditions Patients on immunosuppressive drugs, anticoagulants Bleeding and coagulation disorders, HIV If patient develops serious side effects during treatment If patient wants alternate treatment during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical resolution of lesions, decrease in size and numberTimepoint: AT WEEK 2,4,6,8,10 | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of lesions with complete clearance, decrease in size & number of skin lesions at the end of 3 monthsTimepoint: Week 2,4,6,8,10 & after 1 month, 2 months & 3 months | — |
Countries
India
Contacts
Public ContactSAMHITHA AKEPATI
Government medical college, chengalpattu
Outcome results
None listed